Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25834190 | 0.80 | CA2 (0.39) | — | |
| SCHEMBL25834192 | 0.80 | ALDH1A1 (0.33) | TSHRALDH1A1 | |
| SCHEMBL25834188 | 0.79 | ALDH1A1 (0.32) | TSHRALDH1A1 | |
| Di(Hydroxyethyl)Ether SCHEMBL1790189 | 0.78 | TSHR (0.59) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Di(Hydroxyethyl)Ether SCHEMBL28929647 | 0.78 | TSHR (0.59) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL27026975 | 0.76 | TSHR (0.50) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Triethylene Glycol SCHEMBL29198607 | 0.75 | MEN1 (0.61) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| Hexaethylene Glycol SCHEMBL4154184 | 0.75 | MEN1 (0.61) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL4140373 | 0.75 | MEN1 (0.61) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL4149482 | 0.75 | MEN1 (0.61) | TSHRMAPK1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230218523-A1 | Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230218523-A1 | Ionic Liquid-Based Nanoemulsion Formulation for the Efficient Delivery of Hydrophilic and Hydrophobic Therapeutic Agents | HACD3, C9, HACD2 | TSHR 3859/4885MAPK1 3590/4885MEN1 3082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.